Kuanteng Medical, founded in 2011 and headquartered in Beijing, develops and manufactures a full line of medical imaging equipment including CT, DR, MR and C‑arm systems and key core components. The company reports in‑house R&D and production capabilities across multiple bases (Beijing, Shenyang, Hangzhou and Fuzhou) and completed the 2016 acquisition of Kaipu Medical to build a full industry‑chain layout. Kuanteng says it holds hundreds of intellectual‑property authorizations (200+ patents cited) and has launched more than 30 imaging products, with the CT product line and a photon‑counting detector CT highlighted as industry‑leading. Commercial traction includes rapid recent growth and 2022 sales above CNY 750 million, with roughly 1,600 DR units and over 100 CT units sold. The company also operates a pet‑imaging subsidiary, Dibaocheng, which the article says has the leading domestic pet imaging market share (~40%). Kuanteng plans to use continued R&D, capacity expansion and cost control to deepen penetration across grassroots and tertiary hospitals and to pursue overseas expansion and higher‑end product breakthroughs over the next five years.

Total raised

$14M

Funding rounds

1

Latest round

Series C

Latest activity

Sep 2023